Literature DB >> 25142581

Immunogenicity studies of proteins forming the T4 phage head surface.

Krystyna Dąbrowska1, Paulina Miernikiewicz2, Agnieszka Piotrowicz2, Katarzyna Hodyra2, Barbara Owczarek2, Dorota Lecion2, Zuzanna Kaźmierczak2, Andrey Letarov3, Andrzej Górski4.   

Abstract

UNLABELLED: Advances in phage therapy and novel applications of phages in biotechnology encourage interest in phage impact on human and animal immunity. Here we present comparative studies of immunogenic properties of T4 phage head surface proteins gp23*, gp24*, Hoc, and Soc, both as elements of the phage capsid and as isolated agents. Studies comprise evaluation of specific antibodies in the human population, analysis of the proteins' impact on the primary and secondary responses in mice, and the effect of specific antibodies on phage antibacterial activity in vitro and in vivo in mice. In humans, natural antibodies specific to T4-like phages were abundant (81% of investigated sera). Among those, significantly elevated levels of IgG antibodies only against major head protein (gp23*) were found, which probably reflected cross-reactions of T4 with antibodies induced by other T4-like phages. Both IgM and IgG antibodies were induced mostly by gp23* and Hoc, while weak (gp24*) and very weak (Soc) reactivities of other head proteins were noticed. Thus, T4 head proteins that markedly contribute to immunological memory to the phage are highly antigenic outer capsid protein (Hoc) and major capsid protein (gp23*). Specific anti-gp23* and anti-Hoc antibodies substantially decreased T4 phage activity in vitro and to some extent in vivo. Cooperating with antibodies, the immune complement system also contributed to annihilating phages. IMPORTANCE: Current descriptions of phage immunogenicity and its biological consequences are still vague and incomplete; thus, the central problem of this work is timely and may have strong practical implications. Here is presented the very first description of the contribution of bacteriophage proteins to immunological memory of the phage. Understanding of interactions between phages and mammalian immunology may help in biotechnological adaptations of phages for therapeutic requirements as well as for better appreciation of phage ecology and their role in the biosphere.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25142581      PMCID: PMC4248953          DOI: 10.1128/JVI.02043-14

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  31 in total

1.  Molecular organization of the shell of the Teven bacteriophage head.

Authors:  T Ishii; M Yanagida
Journal:  J Mol Biol       Date:  1975-10-05       Impact factor: 5.469

2.  Studies on bacteriophage penetration in patients subjected to phage therapy.

Authors:  B Weber-Dabrowska; M Dabrowski; S Slopek
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  1987       Impact factor: 4.291

3.  Immunogenic effect of bacteriophage in patients subjected to phage therapy.

Authors:  A Kucharewicz-Krukowska; S Slopek
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  1987       Impact factor: 4.291

4.  Antibodies against staphylococcal bacteriophages in human sera. II. Assay of antibodies in exacerbation and regression of chronic staphylococcal osteomyelitis.

Authors:  S A Hedström; C Kamme
Journal:  Acta Pathol Microbiol Scand B Microbiol Immunol       Date:  1973-12

Review 5.  Molecular organization of the head of bacteriophage Teven: underlying design principles.

Authors:  M Yanagida; Y Suzuki; T Toda
Journal:  Adv Biophys       Date:  1984

6.  Evaluation of CD4+ T cell function In vivo in HIV-infected patients as measured by bacteriophage phiX174 immunization.

Authors:  I Fogelman; V Davey; H D Ochs; M Elashoff; M B Feinberg; J Mican; J P Siegel; M Sneller; H C Lane
Journal:  J Infect Dis       Date:  2000-07-21       Impact factor: 5.226

7.  Factors influencing the survival and multiplication of bacteriophages in calves and in their environment.

Authors:  H W Smith; M B Huggins; K M Shaw
Journal:  J Gen Microbiol       Date:  1987-05

8.  Phage neutralization by sera of patients receiving phage therapy.

Authors:  Marzanna Łusiak-Szelachowska; Maciej Zaczek; Beata Weber-Dąbrowska; Ryszard Międzybrodzki; Marlena Kłak; Wojciech Fortuna; Sławomir Letkiewicz; Paweł Rogóż; Krzysztof Szufnarowski; Ewa Jończyk-Matysiak; Barbara Owczarek; Andrzej Górski
Journal:  Viral Immunol       Date:  2014-06-03       Impact factor: 2.257

9.  Antibodies against staphylococcal bacteriophages in human sera. I. Assay of antibodies in healthy individuals and in patients with staphylococcal infections.

Authors:  C Kamme
Journal:  Acta Pathol Microbiol Scand B Microbiol Immunol       Date:  1973-12

10.  Preparation of endotoxin-free bacteriophages.

Authors:  Janusz Boratyński; Danuta Syper; Beata Weber-Dabrowska; Marzanna Łusiak-Szelachowska; Gryzelda Poźniak; Andrzej Górski
Journal:  Cell Mol Biol Lett       Date:  2004       Impact factor: 5.787

View more
  46 in total

Review 1.  Ménage à trois in the human gut: interactions between host, bacteria and phages.

Authors:  Mohammadali Khan Mirzaei; Corinne F Maurice
Journal:  Nat Rev Microbiol       Date:  2017-05-02       Impact factor: 60.633

2.  Phage Therapy of Pneumonia Is Not Associated with an Overstimulation of the Inflammatory Response Compared to Antibiotic Treatment in Mice.

Authors:  Nicolas Dufour; Raphaëlle Delattre; Anne Chevallereau; Jean-Damien Ricard; Laurent Debarbieux
Journal:  Antimicrob Agents Chemother       Date:  2019-07-25       Impact factor: 5.191

Review 3.  Pharmacologically Aware Phage Therapy: Pharmacodynamic and Pharmacokinetic Obstacles to Phage Antibacterial Action in Animal and Human Bodies.

Authors:  Krystyna Dąbrowska; Stephen T Abedon
Journal:  Microbiol Mol Biol Rev       Date:  2019-10-30       Impact factor: 11.056

4.  Elevated plasma phage load as a marker for intestinal permeability in leukemic patients.

Authors:  Xue-Rui Yin; Ping Liu; Xi Xu; Ying Xia; Kai-Zhao Huang; Qiong-Dan Wang; Mei-Mei Lai; Qi-Gui Yu; Xiao-Qun Zheng
Journal:  Med Microbiol Immunol       Date:  2020-09-29       Impact factor: 3.402

5.  Natural and Induced Antibodies Against Phages in Humans: Induction Kinetics and Immunogenicity for Structural Proteins of PB1-Related Phages.

Authors:  Katarzyna Hodyra-Stefaniak; Zuzanna Kaźmierczak; Joanna Majewska; Sanna Sillankorva; Paulina Miernikiewicz; Ryszard Międzybrodzki; Andrzej Górski; Joana Azeredo; Rob Lavigne; Dorota Lecion; Sylwia Nowak; Marek Harhala; Patryk Waśko; Barbara Owczarek; Katarzyna Gembara; Krystyna Dąbrowska
Journal:  Phage (New Rochelle)       Date:  2020-06-16

Review 6.  Phages and their potential to modulate the microbiome and immunity.

Authors:  Sara Federici; Samuel P Nobs; Eran Elinav
Journal:  Cell Mol Immunol       Date:  2020-09-08       Impact factor: 11.530

7.  Neutralizing antibody response against subcutaneously injected bacteriophages in rabbit model.

Authors:  Archana Archana; Prem Shankar Patel; Rajesh Kumar; Gopal Nath
Journal:  Virusdisease       Date:  2021-03-10

8.  Bacteriophages immunomodulate the response of monocytes.

Authors:  Lídia Perea; Lorena Rodríguez-Rubio; Juan C Nieto; Carlos Zamora; Elisabet Cantó; German Soriano; Maria Poca; Pedro Blanco-Picazo; Ferran Navarro; Maite Muniesa; Silvia Vidal
Journal:  Exp Biol Med (Maywood)       Date:  2021-02-27

Review 9.  Clinical Pharmacology of Bacteriophage Therapy: A Focus on Multidrug-Resistant Pseudomonas aeruginosa Infections.

Authors:  Dana Holger; Razieh Kebriaei; Taylor Morrisette; Katherine Lev; Jose Alexander; Michael Rybak
Journal:  Antibiotics (Basel)       Date:  2021-05-11

Review 10.  Temperate Bacteriophages-The Powerful Indirect Modulators of Eukaryotic Cells and Immune Functions.

Authors:  Martyna Cieślik; Natalia Bagińska; Ewa Jończyk-Matysiak; Alicja Węgrzyn; Grzegorz Węgrzyn; Andrzej Górski
Journal:  Viruses       Date:  2021-05-28       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.